{"id":6596,"date":"2026-07-20T14:13:56","date_gmt":"2026-07-20T12:13:56","guid":{"rendered":"https:\/\/mumak.me\/?p=6596"},"modified":"2026-07-22T15:06:55","modified_gmt":"2026-07-22T13:06:55","slug":"exxonmobil-q1-2026-earnings-update-2","status":"publish","type":"post","link":"https:\/\/mumak.me\/en\/portfolio-updates\/company-update\/exxonmobil-q1-2026-earnings-update-2\/","title":{"rendered":"Johnson &#038; Johnson \u2013 Q2 2026 Earnings Update"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"6596\" class=\"elementor elementor-6596 elementor-6595\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-21f229a e-flex e-con-boxed e-con e-parent\" data-id=\"21f229a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c7c5ed1 elementor-widget elementor-widget-text-editor\" data-id=\"c7c5ed1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3 aria-level=\"2\"><b><span data-contrast=\"none\">Johnson &#038; Johnson: Quality in Uncertain Times <\/span><\/b><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"134245418\":true,\"134245529\":true,\"201341983\":0,\"335551550\":1,\"335551620\":1,\"335559685\":0,\"335559737\":0,\"335559738\":160,\"335559739\":80,\"335559740\":279}\"> <\/span><\/h3><p><a href=\"https:\/\/mumak.me\/en\/inside-umbrella\/stocks\/stock-johnson-johnson\/\"><b><span data-contrast=\"none\">Johnson &#038; Johnson (NYSE: JNJ)<\/span><\/b><\/a><span data-contrast=\"none\"> reported better-than-expected results for the second quarter of 2026, once again demonstrating the strength of its broadly diversified healthcare business. While reported earnings remained nearly unchanged due to special effects related to acquisitions and restructuring, operational development continued positively across all major business segments.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":240,\"335559739\":240}\"> <\/span><\/p><p><span data-contrast=\"none\">Furthermore, management raised the full-year 2026 guidance, underscoring confidence in continued robust demand for innovative medicines and medical technology \u2013 despite the ongoing challenging macroeconomic environment.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":240,\"335559739\":240}\"> <\/span><\/p><h3 aria-level=\"3\"><span data-contrast=\"none\">Q2 2026 at a Glance<\/span><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-26127d1 elementor-widget elementor-widget-Table\" data-id=\"26127d1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"Table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<table class=\"tafe-table \">\n\t\t\t<thead  class=\"tafe-table-header\">\n\t\t\t\t<tr>\n\t\t\t\t\t<th class=\"elementor-inline-editing elementor-repeater-item-3f3f2e0\"   >Key Figure<\/th><th class=\"elementor-inline-editing elementor-repeater-item-f44885d\"   >Q2 2026 <\/th><th class=\"elementor-inline-editing elementor-repeater-item-23de24f\"   >Year-over-Year Change <\/th>\t\t\t\t<\/tr>\n\t\t\t<\/thead>\n\t\t\t\t\t\t<tbody class=\"tafe-table-body\">\n\t\t\t\t<tr>\n\t\t\t\t\t<\/tr><tr><td data-label=\"Key Figure\"   class=\"elementor-repeater-item-e050aa7 td-content-type-default\" ><b>Revenue <\/b><\/td><td data-label=\"Q2 2026\"   class=\"elementor-repeater-item-da32a54 td-content-type-default\" >$25.3 billion<\/td><td data-label=\"Year-over-Year Change\"   class=\"elementor-repeater-item-f04d525 td-content-type-default\" >+6,6 %<\/td><\/tr><tr><td data-label=\"Key Figure\"   class=\"elementor-repeater-item-66a0f10 td-content-type-default\" ><b>Operational Revenue Growth <\/b><\/td><td data-label=\"Q2 2026\"   class=\"elementor-repeater-item-8d40194 td-content-type-default\" >\u2013\n<\/td><td data-label=\"Year-over-Year Change\"   class=\"elementor-repeater-item-7647d0a td-content-type-default\" >+5,6 %\n<\/td><\/tr><tr><td data-label=\"Key Figure\"   class=\"elementor-repeater-item-7c6426a td-content-type-default\" ><b>Adjusted EPS <\/b><\/td><td data-label=\"Q2 2026\"   class=\"elementor-repeater-item-60bcf94 td-content-type-default\" >$2.90 \n<\/td><td data-label=\"Year-over-Year Change\"   class=\"elementor-repeater-item-1e54240 td-content-type-default\" >+4,7 %\n<\/td><\/tr><tr><td data-label=\"Key Figure\"   class=\"elementor-repeater-item-d27b099 td-content-type-default\" ><b>Adjusted Net Income<\/b><\/td><td data-label=\"Q2 2026\"   class=\"elementor-repeater-item-08a1df6 td-content-type-default\" >$7.1 billion \n<\/td><td data-label=\"Year-over-Year Change\"   class=\"elementor-repeater-item-3dfb4de td-content-type-default\" >+5,7 % \n<\/td><\/tr><tr><td data-label=\"Key Figure\"   class=\"elementor-repeater-item-e014835 td-content-type-default\" ><b>Free Cash Flow <\/b><\/td><td data-label=\"Q2 2026\"   class=\"elementor-repeater-item-96a1917 td-content-type-default\" >approx. $8.7 billion\n<\/td><td data-label=\"Year-over-Year Change\"   class=\"elementor-repeater-item-4234277 td-content-type-default\" >approx. +40%\n<\/td>\t\t\t\t<\/tr>\n\t\t\t<\/tbody>\n\t\t<\/table>\n\t\t\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a0af1ca elementor-widget elementor-widget-text-editor\" data-id=\"a0af1ca\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4 aria-level=\"3\"><span data-contrast=\"none\">Key Highlights<\/span><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/h4><ul><li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{\"335552541\":1,\"335559683\":0,\"335559684\":-2,\"335559685\":720,\"335559991\":360,\"469769226\":\"Symbol\",\"469769242\":[8226],\"469777803\":\"left\",\"469777804\":\"\uf0b7\",\"469777815\":\"hybridMultilevel\"}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"none\">Revenue exceeded market expectations, driven by broad-based growth in the <\/span><b><span data-contrast=\"none\">Innovative Medicine<\/span><\/b><span data-contrast=\"none\"> and <\/span><b><span data-contrast=\"none\">MedTech<\/span><\/b><span data-contrast=\"none\"> segments.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":0,\"335559739\":0}\"> <\/span><\/li><\/ul><ul><li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{\"335552541\":1,\"335559683\":0,\"335559684\":-2,\"335559685\":720,\"335559991\":360,\"469769226\":\"Symbol\",\"469769242\":[8226],\"469777803\":\"left\",\"469777804\":\"\uf0b7\",\"469777815\":\"hybridMultilevel\"}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"none\">The operational revenue growth of <\/span><b><span data-contrast=\"none\">5.6%<\/span><\/b><span data-contrast=\"none\"> reflects continued strong demand despite negative currency effects.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":0,\"335559739\":0}\"> <\/span><\/li><\/ul><ul><li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{\"335552541\":1,\"335559683\":0,\"335559684\":-2,\"335559685\":720,\"335559991\":360,\"469769226\":\"Symbol\",\"469769242\":[8226],\"469777803\":\"left\",\"469777804\":\"\uf0b7\",\"469777815\":\"hybridMultilevel\"}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"none\">Adjusted earnings per share (EPS) rose to <\/span><b><span data-contrast=\"none\">$2.90<\/span><\/b><span data-contrast=\"none\">, supported by improved operational efficiency and consistent execution of the corporate strategy.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":0,\"335559739\":0}\"> <\/span><\/li><\/ul><ul><li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{\"335552541\":1,\"335559683\":0,\"335559684\":-2,\"335559685\":720,\"335559991\":360,\"469769226\":\"Symbol\",\"469769242\":[8226],\"469777803\":\"left\",\"469777804\":\"\uf0b7\",\"469777815\":\"hybridMultilevel\"}\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"none\">Free cash flow increased significantly, further strengthening the group&#8217;s already solid financial position.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":0,\"335559739\":0}\"> <\/span><\/li><\/ul><ul><li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{\"335552541\":1,\"335559683\":0,\"335559684\":-2,\"335559685\":720,\"335559991\":360,\"469769226\":\"Symbol\",\"469769242\":[8226],\"469777803\":\"left\",\"469777804\":\"\uf0b7\",\"469777815\":\"hybridMultilevel\"}\" data-aria-posinset=\"5\" data-aria-level=\"1\"><span data-contrast=\"none\">Management raised the <\/span><b><span data-contrast=\"none\">2026 full-year guidance<\/span><\/b><span data-contrast=\"none\">, signaling confidence in further business development.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":0,\"335559739\":0}\"> <\/span><\/li><\/ul><p aria-level=\"3\"><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/p><h4 aria-level=\"3\"><span data-contrast=\"none\">What Defined the Quarter?<\/span><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/h4><p><span data-contrast=\"none\">The most important growth drivers once again came from the <\/span><b><span data-contrast=\"none\">Innovative Medicine<\/span><\/b><span data-contrast=\"none\"> segment. In particular, the therapeutic areas of <\/span><b><span data-contrast=\"none\">oncology<\/span><\/b><span data-contrast=\"none\">, <\/span><b><span data-contrast=\"none\">immunology<\/span><\/b><span data-contrast=\"none\">, and <\/span><b><span data-contrast=\"none\">neuroscience<\/span><\/b><span data-contrast=\"none\"> recorded sustained strong demand.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":240,\"335559739\":240}\"> <\/span><\/p><p><span data-contrast=\"none\">The <\/span><b><span data-contrast=\"none\">MedTech<\/span><\/b><span data-contrast=\"none\"> segment also continued its positive trend. A further recovery in procedure volumes and the gradual normalization of procurement activities in hospitals provided additional growth momentum.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":240,\"335559739\":240}\"> <\/span><\/p><h3 aria-level=\"3\"><span data-contrast=\"none\">Segment Revenue \u2013 Q2 2026<\/span><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/h3>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-85bc021 elementor-widget elementor-widget-Table\" data-id=\"85bc021\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"Table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<table class=\"tafe-table \">\n\t\t\t<thead  class=\"tafe-table-header\">\n\t\t\t\t<tr>\n\t\t\t\t\t<th class=\"elementor-inline-editing elementor-repeater-item-3f3f2e0\"   >Segment<\/th><th class=\"elementor-inline-editing elementor-repeater-item-f44885d\"   >Q2 2026 (M USD) <\/th><th class=\"elementor-inline-editing elementor-repeater-item-23de24f\"   >Q2 2025 (M USD)<\/th><th class=\"elementor-inline-editing elementor-repeater-item-160e477\"   >Reported Growth<\/th><th class=\"elementor-inline-editing elementor-repeater-item-7cd4f92\"   >Operational Growth<\/th>\t\t\t\t<\/tr>\n\t\t\t<\/thead>\n\t\t\t\t\t\t<tbody class=\"tafe-table-body\">\n\t\t\t\t<tr>\n\t\t\t\t\t<\/tr><tr><td data-label=\"Segment\"   class=\"elementor-repeater-item-e050aa7 td-content-type-default\" ><b>Innovative <\/b><\/td><td data-label=\"Q2 2026 (M USD)\"   class=\"elementor-repeater-item-da32a54 td-content-type-default\" >27x <\/td><td data-label=\"Q2 2025 (M USD)\"   class=\"elementor-repeater-item-f04d525 td-content-type-default\" >approx. 21\u201324x  <\/td><td data-label=\"Reported Growth\"   class=\"elementor-repeater-item-88aee7f td-content-type-default\" >+7,8 %  <\/td><td data-label=\"Operational Growth\"   class=\"elementor-repeater-item-464843f td-content-type-default\" >+6,8 %  <\/td><\/tr><tr><td data-label=\"Segment\"   class=\"elementor-repeater-item-66a0f10 td-content-type-default\" ><b>Medicine MedTech <\/b><\/td><td data-label=\"Q2 2026 (M USD)\"   class=\"elementor-repeater-item-8d40194 td-content-type-default\" >28 % \n<\/td><td data-label=\"Q2 2025 (M USD)\"   class=\"elementor-repeater-item-7647d0a td-content-type-default\" >approx. 22\u201328%\n<\/td><td data-label=\"Reported Growth\"   class=\"elementor-repeater-item-b467be0 td-content-type-default\" >+4,5 %  <\/td><td data-label=\"Operational Growth\"   class=\"elementor-repeater-item-d7edc25 td-content-type-default\" >+3,6 %  <\/td><\/tr><tr><td data-label=\"Segment\"   class=\"elementor-repeater-item-d27b099 td-content-type-default\" ><b>Group Total <\/b><\/td><td data-label=\"Q2 2026 (M USD)\"   class=\"elementor-repeater-item-08a1df6 td-content-type-default\" >approx. 6%\n<\/td><td data-label=\"Q2 2025 (M USD)\"   class=\"elementor-repeater-item-3dfb4de td-content-type-default\" >approx. 4\u20137%\n<\/td><td data-label=\"Reported Growth\"   class=\"elementor-repeater-item-13b2ed6 td-content-type-default\" >+6,6 % \n<\/td><td data-label=\"Operational Growth\"   class=\"elementor-repeater-item-46e4acf td-content-type-default\" >+5,6 %\n<\/td>\t\t\t\t<\/tr>\n\t\t\t<\/tbody>\n\t\t<\/table>\n\t\t\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2b81296 elementor-widget elementor-widget-text-editor\" data-id=\"2b81296\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><i><span data-contrast=\"none\">Source: <\/span><\/i><a href=\"https:\/\/s203.q4cdn.com\/636242992\/files\/doc_financials\/2026\/q2\/2Q26-Earnings-Press-Release-Final.pdf\" rel=\"nofollow noopener\" target=\"_blank\"><i><span data-contrast=\"none\">Johnson &#038; Johnson, Q2 2026 Quarterly Report<\/span><\/i><\/a><i><span data-contrast=\"none\">.<\/span><\/i><span data-ccp-props=\"{}\"> <\/span><\/p><p aria-level=\"3\"><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/p><h3 aria-level=\"3\"><b><span data-contrast=\"none\">MUMAK Assessment<\/span><\/b><span data-ccp-props=\"{\"134245418\":true,\"134245529\":true,\"335559738\":160,\"335559739\":80}\"> <\/span><\/h3><p><span data-contrast=\"none\">The current quarterly figures confirm our positive long-term assessment of <\/span><b><span data-contrast=\"none\">Johnson &#038; Johnson<\/span><\/b><span data-contrast=\"none\">.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":240,\"335559739\":240}\"> <\/span><\/p><p><span data-contrast=\"none\">The combination of  <\/span><b><span data-contrast=\"none\">stable cash flows<\/span><\/b><span data-contrast=\"none\">,  <\/span><b><span data-contrast=\"none\">improved earnings quality<\/span><\/b><span data-contrast=\"none\">, a  <\/span><b><span data-contrast=\"none\">broadly diversified healthcare portfolio<\/span><\/b><span data-contrast=\"none\"> , and the  <\/span><b><span data-contrast=\"none\">raised full-year guidance<\/span><\/b><span data-contrast=\"none\">  underscores the company&#8217;s current role as a defensive core holding within the UMBRELLA strategy. <\/span><b><span data-contrast=\"none\">UMBRELLA Strategy<\/span><\/b><span data-contrast=\"none\">.<\/span><span data-ccp-props=\"{\"134233117\":false,\"134233118\":false,\"335551550\":0,\"335551620\":0,\"335559738\":240,\"335559739\":240}\"> <\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Johnson &#038; Johnson impresses with strong Q2 2026 figures, significantly increasing revenue and free cash flow while raising its guidance for the full year.<\/p>\n","protected":false},"author":2,"featured_media":2171,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[151],"tags":[504],"aktie":[372],"class_list":["post-6596","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-update","tag-johnson","aktie-johnson-johnson"],"acf":[],"_links":{"self":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/6596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/comments?post=6596"}],"version-history":[{"count":6,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/6596\/revisions"}],"predecessor-version":[{"id":6614,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/6596\/revisions\/6614"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media\/2171"}],"wp:attachment":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media?parent=6596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/categories?post=6596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/tags?post=6596"},{"taxonomy":"aktie","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/aktie?post=6596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}